Sireesh Appajosyula insider trades

Open-market stock purchases and sales by Sireesh Appajosyula, Chief Operating Officer at Hepion Pharmaceuticals, Inc, from SEC Form 4 filings since Mar 21, 2022.

Track record: 100% of 5 scored buys are up 5% or more since purchase, averaging +176%.

Recent trades

DateStockTradeValue
Aug 19, 2026HEPA Hepion Pharmaceuticals, IncBought (not open market)—
Aug 3, 2026HEPA Hepion Pharmaceuticals, IncBought$100K
Aug 3, 2026HEPA Hepion Pharmaceuticals, IncBought—
Apr 21, 2026HEPA Hepion Pharmaceuticals, IncBought$50K
Nov 3, 2025THAR Tharimmune, IncBought (not open market)—

Companies traded

  • HEPA Hepion Pharmaceuticals, Inc: 3 buys, last Aug 19, 2026
  • THAR Tharimmune, Inc: 5 buys, last Nov 3, 2025
  • HILS Hillstream BioPharma Inc: other filings, last Jul 14, 2022

Get free alerts when Sireesh Appajosyula files a new trade →